{{Rsnum
|rsid=5210
|Gene=KCNJ11
|Chromosome=11
|position=17386704
|Orientation=plus
|GMAF=0.466
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=KCNJ11
}}{{PMID Auto
|PMID=19799532
|Title=Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs
}}

{{PMID Auto
|PMID=16733889
|Title=[Association analysis of 30 type 2 diabetes candidate genes in Chinese Han population].
}}

{{PMID Auto
|PMID=17192490
|Title=Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes.
}}

{{PMID Auto
|PMID=18599530
|Title=Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients.
|OA=1
}}

{{PMID Auto
|PMID=18678618
|Title=Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes.
|OA=1
}}

{{PMID Auto
|PMID=21573802
|Title=Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42,573 individuals.
}}

{{PMID Auto
|PMID=23544998
|Title=Association of TRPC1 gene polymorphisms with type 2 diabetes and diabetic nephropathy in Han Chinese population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}